Diabetes

Julie Schulz, MD, MPH, discusses GLP-1 receptor agonists, the lab’s role in prescribing, and the future of the GLP-1 drug industry 

Curated resources on how testing methods and hemoglobin variants impact HbA1c accuracy—and what labs can do to ensure reliable results

Discover key insights into how automated HPLC systems provide reliable A1c results with detection of commonly occurring hemoglobin variants for optimum management of diabetes

Medway NHS Foundation Trust to transform local gestational diabetes screening by improving access to a new at-home diabetes testing technology

Two distinct signatures were detected in a subset of circulating, highly differentiated CD8-positive T cells in children at different stages of T1D

Increase in T2D research comes at time of rising interest in GLP-1s, including Ozempic and Wegovy

Each year in the US, cases of type 2 diabetes in youth increase by 5.3 percent—the prevalence is expected to increase by 700 percent by 2060

The updated guideline recommends adding an SGLT-2 inhibitor or GLP-1 agonist to metformin

New study suggests the placenta is a key factor in the development of gestational diabetes

Users should not make medical decisions based on the device’s output without talking to their healthcare provider